Delivery Order SPE2DB22D2006-SPE2DB25FW2UR
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,596.30 firm fixed price delivery order contract to supply 4,564,159,068 ONFI 10 MG tablets in 100-count packages. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.44, is a firm fixed-price delivery order for 4,568,105,655 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $6,271.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a performance period ending on April 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,399.62 firm fixed-price delivery order is for the supply of 4566976761 ONFI 10 MG TABLET 100S, with a completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,050.32, is a delivery order with a firm fixed price. It is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,621.20 fixed-price delivery order is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is not associated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564802449 ONFI 20 MG TABLET 100S. The firm-fixed-price delivery order has a ceiling value of $6,786.18 and an ultimate completion date of June 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, holds a significant...
- This federal contract award is a $4,086.24 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, with a period of performance ending on July 9, 2025. The contract is not set aside for any special category of business. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This $8,679.22 delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4566087993 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for providing a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2URDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for ONFI 10 mg tablets in quantities of 100 units, with a contract value of $7,611.88 and a firm fixed price structure. This non-set-aside award is classified as a delivery order under a competitive procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. The DLA, a defense agency under the Department of Defense, procures medical supplies and pharmaceuticals to support military healthcare operations globally. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts and demonstrates capability to fulfill federal procurement requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 7/24/25 |